IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kiniksa Pharmaceuticals

CUSIP: G5269C101 | 315 institutional holders

Quarters

Q3 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Harbor Capital Advisors, Inc.530
0.0% of portfolio›$40
StyleTurnoverLocationFiled
Harbor Capital Advisors, Inc.
530$400.0%ValueHighChicago, IL2026-10-22